>
IT'S OVER: Banks Tap Fed for $17 BILLION as Silver Shorts Implode
SEMI-NEWS/SEMI-SATIRE: December 28, 2025 Edition
China Will Close the Semiconductor Gap After EUV Lithography Breakthrough
The Five Big Lies of Vaccinology
EngineAI T800: Born to Disrupt! #EngineAI #robotics #newtechnology #newproduct
This Silicon Anode Breakthrough Could Mark A Turning Point For EV Batteries [Update]
Travel gadget promises to dry and iron your clothes – totally hands-free
Perfect Aircrete, Kitchen Ingredients.
Futuristic pixel-raising display lets you feel what's onscreen
Cutting-Edge Facility Generates Pure Water and Hydrogen Fuel from Seawater for Mere Pennies
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China

Date:
January 12, 2017
Source:
Buck Institute for Research on Aging
Summary:
One of the challenges in developing stem cell therapies is ensuring that transplanted cells can survive long enough to work. Researchers report one of the first demonstrations of long-term vision restoration in blind mice by transplanting photoreceptors derived from human stem cells and blocking the immune response that causes transplanted cells to be rejected. The findings support a path to improving clinical applications in restoring human vision lost to degenerative eye diseases.